<DOC>
	<DOCNO>NCT01234558</DOCNO>
	<brief_summary>The purpose study determine whether GLYX-13 reduces depression score patient treatment-resistant depression .</brief_summary>
	<brief_title>Single IV Dose GLYX-13 Patients With Treatment-Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>diagnosis major depressive disorder consistent DSMIVTR current episode great 8 week duration Hamilton Depression score &gt; / 21 less 25 % reduction depression current episode assess ATRQ Axis diagnosis psychiatric disorder Experiencing hallucination , delusion , psychotic symptomatology ECT current episode</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>depression</keyword>
	<keyword>NMDA antagonist</keyword>
	<keyword>treatment resistant</keyword>
</DOC>